Small Cell Lung Carcinoma clinical trials

Explore recruiting small cell lung carcinoma clinical trials.

Recruiting small cell lung carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Small Cell Lung Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase I trial of CArbonic Anhydrase Inhibition in combination with radiochemotherapy or radioimmunotherapy in small cell lung carcinoma (ICAR)

France

Human Pharmacology (Phase I)- Other EU CTIS Study details

Dose tapering and Early Discontinuation to InCreAse cosT-effictIveness Of immunotherapy for Non-small cell lung carcinoma trial number 1 (NVALT-30 - Dedication-1)

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

A study to test different doses of obrixtamig (BI 764532) combined with ezabenlimab in patients with Small Cell Lung Carcinoma and other neuroendocrine neoplasms expressing DLL3

Belgium, France, Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Study Investigating Tucatinib and Osimertinib Pharmacokinetics in Primary and Metastatic Brain Tumors: the STICK trial

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

DAREON™-8: A study to test how well different doses of BI 764532 in addition to standard of care are tolerated by people with advanced small cell lung cancer

Poland, Belgium, France, Germany, Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Evaluating T Cell Changes and Activation in Cancer Patient Using Two PET Tracers (iRelate)

Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

Small Cell Lung Carcinoma trials by city

Small Cell Lung Carcinoma clinical trials

Recruiting small cell lung carcinoma studies right now

AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer

Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors

ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs

Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Concomitant Use of Radiotherapy and Integrated Exercise - Lung Cancer

Also recruiting in Europe

Phase I trial of CArbonic Anhydrase Inhibition in combination with radiochemotherapy or radioimmunotherapy in small cell lung carcinoma (ICAR)

Dose tapering and Early Discontinuation to InCreAse cosT-effictIveness Of immunotherapy for Non-small cell lung carcinoma trial number 1 (NVALT-30 - Dedication-1)

A study to test different doses of obrixtamig (BI 764532) combined with ezabenlimab in patients with Small Cell Lung Carcinoma and other neuroendocrine neoplasms expressing DLL3

Study Investigating Tucatinib and Osimertinib Pharmacokinetics in Primary and Metastatic Brain Tumors: the STICK trial

DAREON™-8: A study to test how well different doses of BI 764532 in addition to standard of care are tolerated by people with advanced small cell lung cancer

Evaluating T Cell Changes and Activation in Cancer Patient Using Two PET Tracers (iRelate)

Small Cell Lung Carcinoma trials by city

Other conditions